4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-086416
Chief Patient Supply Officer sold 3,096 shares at $0.91 ($2,804)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lunger John Chief Patient Supply Officer | 2023-08-01 | Sale | −3,096 | $0.91 | $2,804 | 4,718 | D: show line 1 in the form |
| Open-market sales · 3,096 sh · avg $0.91 · $2,804 | |||||||
Loading xslF345X05/tm2320966-2_4seq1.xml…